There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
Sierra Sun Times15h
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
MedPage Today2d
First Generic of Once-Daily GLP-1 Injection Approved for Diabetes
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
FDA approves GLP-1 generic for Type 2 diabetes
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...
Indies Pharma looks to earn from FDA-approved drug next year
Following the recent approval of its Regadenoson generic drug by the United States Food and Drug Administration (FDA), Indies ...
Medscape2d
FDA Approves Second Generic Daily GLP-1 Drug for T2D
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
Vermont Business Magazine2d
Welch introduces bipartisan Skinny Labels, Big Savings Act to safeguard generic drugs, slash drug prices
“This bipartisan legislation will promote generic drug competition and improve patient access to lower-cost medications,” said Senator Collins. “By reaffirming the so-called ‘skinny label’ pathway, ...
Managed Healthcare Executive1d
FDA Approves First Once-Daily Generic of Victoza for Type 2 Diabetes
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
The American Journal of Managed Care2d
FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...